UPICT Alzheimer's Disease/ Dementia Imaging Protocol Writing Group

Project Snapshot

This writing group,Uniform Protocols for Imaging in Clinical Trials (UPICT) Alzheimer’s/Dementia (AD) Imaging Protocol Writing Group,is part of the broader UPICT effort - the focus of which is to define standardized imaging protocols for use in clinical trials. UPICT’s goal is to improve the likelihood that data derived from imaging studies performed during clinical trials are reflective of the pathophysiologic processes of interest rather than being secondary to artifacts attributable to variance in the performance and analyses of the imaging. UPICT is sponsored in part by a multi-institutional grant program of the National Institutes of Health (the Clinical and Translational Science Awards or CTSA) in partnership with the Radiological Society of North America (RSNA).

As part of the UPICT process, our Writing Group’s goal is to define a consensus standard MR image acquisition protocol for use in AD clinical trials. Our initial objective is to define an image acquisition protocol for volumetric and safety MRI at 1.5T.

Patricia E. Cole, PhD, MD, (Chair: UPICT Alzheimer’s/Dementia (AD) Imaging Protocol Writing Group)